Nystatin + Thiostrepton + Neomycin Sulfate + Triamcinolone Acetonide
29 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
29
Total Reports
1
Deaths Reported
340.0%
Death Rate
Active Ingredients
Nystatin + Thiostrepton + Neomycin Sulfate + Triamcinolone Acetonide
Administration Routes
UnknownAuricular (Otic)TopicalCutaneousSubcutaneous
Species Affected
Dog 26
Cat 3
Most Affected Breeds
Crossbred Canine/dog 4
Retriever - Golden 3
Pug 2
Terrier - West Highland White 2
Bulldog 2
Domestic Shorthair 2
Retriever - Labrador 1
Maltese 1
Hound - Basset 1
Retriever (unspecified) 1
Most Reported Reactions
Emesis 9
Elevated alanine aminotransferase (ALT) 7
Lethargy (see also Central nervous system depression in 'Neurological') 4
Lack of efficacy - NOS 4
Vomiting 4
Behavioural disorder NOS 3
Elevated creatinine 3
Leucopenia NOS 3
Other abnormal test result NOS 3
Seizure NOS 2
Diarrhoea 2
UNPALATABLE 2
Outcome Breakdown
Recovered/Normal
16 (55.2%)
Outcome Unknown
5 (17.2%)
Ongoing
5 (17.2%)
Recovered with Sequela
2 (6.9%)
Died
1 (3.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.